Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 2 Trial: Talabostat in Chronic Lymphocytic Leukemia
Uprichard, Margaret J.
Point Therapeutics, Inc., Boston, MA, United States
Search grants from Margaret Uprichard
Search grants from Point Therapeutics, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mechanistic and Therapeutic Role of the CD137-CD137L Axis in Type 1 Diabetes
Yale Pathology Tissue Services Shared Resource
Role of Smad proteins in cell growth regulation
Improving HIV/AIDS/Sti/Tb Related Public Health Practice & Servie Delivery
Computational Modeling of Interiors of Sub-Neptunes and Gas Giant Planets
Recently added grants:
Back-irradiated flat panel imager with avalanche gain
High accuracy optical growth assay of 3D cellular systems
Multiplex nucleosome-based profiling for the development of next-generation chromatin labeling reagents
Nuclear import of beta-Catenin in Wnt-signaling
Theory and Modeling of Biomolecules and their Interactions
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Research Project (R01)
Project #
5R01FD003021-02
Application #
7128133
Study Section
Special Emphasis Panel (ZFD1-OPD (01))
Program Officer
Ganti, Usha
Project Start
2005-09-30
Project End
2007-06-30
Budget Start
2006-09-30
Budget End
2007-06-30
Support Year
2
Fiscal Year
2006
Total Cost
Indirect Cost
Institution
Name
Point Therapeutics, Inc.
Department
Type
DUNS #
829400415
City
Boston
State
MA
Country
United States
Zip Code
02110
Related projects
NIH 2006
R01 FD
Phase 2 Trial: Talabostat in Chronic Lymphocytic Leukemia
Uprichard, Margaret J. / Point Therapeutics, Inc.
NIH 2005
R01 FD
Phase 2 Trial: Talabostat in Chronic Lymphocytic Leukemia
Uprichard, Margaret J. / Point Therapeutics, Inc.
Comments
Be the first to comment on Margaret Uprichard's grant